

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.82993920 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.66732627 |
| 3 | exogenous drug catabolic process (GO:0042738) | 7.61960366 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55323918 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.55323918 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.21542638 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.21542638 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.64761402 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.40367179 |
| 10 | regulation of plasminogen activation (GO:0010755) | 6.36344368 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.88705098 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.88705098 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.88705098 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.80377597 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.74399458 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.68304341 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.66150026 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.62908627 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.56820717 |
| 20 | urea cycle (GO:0000050) | 5.52842527 |
| 21 | urea metabolic process (GO:0019627) | 5.52842527 |
| 22 | ethanol metabolic process (GO:0006067) | 5.46964728 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46900892 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.44359580 |
| 25 | cysteine metabolic process (GO:0006534) | 5.41957134 |
| 26 | protein carboxylation (GO:0018214) | 5.37810322 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37810322 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.36145121 |
| 29 | drug metabolic process (GO:0017144) | 5.24855249 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.20797596 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.16182758 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.09616528 |
| 33 | reverse cholesterol transport (GO:0043691) | 5.01036236 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.99728469 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 4.96489976 |
| 36 | bile acid metabolic process (GO:0008206) | 4.96459779 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.92360569 |
| 38 | oxidative demethylation (GO:0070989) | 4.91298130 |
| 39 | opsonization (GO:0008228) | 4.83804948 |
| 40 | negative regulation of hemostasis (GO:1900047) | 4.83480949 |
| 41 | negative regulation of blood coagulation (GO:0030195) | 4.83480949 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83342089 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.83342089 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.83342089 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.83275083 |
| 46 | regulation of complement activation (GO:0030449) | 4.82908333 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.70816750 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.70363130 |
| 49 | negative regulation of protein activation cascade (GO:2000258) | 4.69316619 |
| 50 | phospholipid efflux (GO:0033700) | 4.69095406 |
| 51 | regulation of humoral immune response (GO:0002920) | 4.67713132 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.67285137 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.62227010 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.62227010 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.57819928 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.57819928 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.54639979 |
| 58 | positive regulation of hemostasis (GO:1900048) | 4.51188770 |
| 59 | positive regulation of blood coagulation (GO:0030194) | 4.51188770 |
| 60 | regulation of apoptotic cell clearance (GO:2000425) | 4.50913835 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.46730766 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.43216566 |
| 63 | lysine metabolic process (GO:0006553) | 4.43082682 |
| 64 | lysine catabolic process (GO:0006554) | 4.43082682 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.42636551 |
| 66 | negative regulation of coagulation (GO:0050819) | 4.39103868 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.36033958 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.33414947 |
| 69 | glycine metabolic process (GO:0006544) | 4.31655173 |
| 70 | negative regulation of wound healing (GO:0061045) | 4.30526135 |
| 71 | S-adenosylmethionine metabolic process (GO:0046500) | 4.25945034 |
| 72 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.25419004 |
| 73 | cholesterol efflux (GO:0033344) | 4.25406762 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.22776036 |
| 75 | phenylpropanoid metabolic process (GO:0009698) | 4.21429749 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.21097109 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 4.20425253 |
| 78 | glutamate metabolic process (GO:0006536) | 4.18169887 |
| 79 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.13237162 |
| 80 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.13237162 |
| 81 | positive regulation of coagulation (GO:0050820) | 4.13149103 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 4.11197922 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 4.10820543 |
| 84 | amine catabolic process (GO:0009310) | 4.07824744 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 4.07824744 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 4.05846916 |
| 87 | cellular glucuronidation (GO:0052695) | 4.03867612 |
| 88 | protein-lipid complex subunit organization (GO:0071825) | 4.01250450 |
| 89 | fibrinolysis (GO:0042730) | 4.00901000 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 4.00240397 |
| 91 | blood coagulation, intrinsic pathway (GO:0007597) | 3.98343294 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.97440566 |
| 93 | intestinal cholesterol absorption (GO:0030299) | 3.97341923 |
| 94 | arginine metabolic process (GO:0006525) | 3.94376635 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.94224019 |
| 96 | aldehyde catabolic process (GO:0046185) | 3.90063694 |
| 97 | negative regulation of complement activation (GO:0045916) | 3.89866161 |
| 98 | ethanol oxidation (GO:0006069) | 3.86389599 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84000470 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84000470 |
| 101 | drug catabolic process (GO:0042737) | 3.83834154 |
| 102 | ketone body metabolic process (GO:1902224) | 3.83081964 |
| 103 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.81924743 |
| 104 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.77570394 |
| 105 | cofactor catabolic process (GO:0051187) | 3.75516622 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.75258798 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.75156925 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.73731868 |
| 109 | alkaloid metabolic process (GO:0009820) | 3.73375755 |
| 110 | negative regulation of lipase activity (GO:0060192) | 3.72138212 |
| 111 | sterol homeostasis (GO:0055092) | 3.69580530 |
| 112 | proline metabolic process (GO:0006560) | 3.68787811 |
| 113 | organic acid catabolic process (GO:0016054) | 3.68719457 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.68719457 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68673437 |
| 116 | protein activation cascade (GO:0072376) | 3.68653001 |
| 117 | plasma lipoprotein particle organization (GO:0071827) | 3.67698408 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.67591858 |
| 119 | acute inflammatory response (GO:0002526) | 3.67440860 |
| 120 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64696905 |
| 121 | complement activation, classical pathway (GO:0006958) | 3.63922493 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 3.63826727 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.62041999 |
| 124 | complement activation (GO:0006956) | 3.59534508 |
| 125 | uronic acid metabolic process (GO:0006063) | 3.57556890 |
| 126 | glucuronate metabolic process (GO:0019585) | 3.57556890 |
| 127 | acute-phase response (GO:0006953) | 3.54543805 |
| 128 | flavonoid metabolic process (GO:0009812) | 3.53118197 |
| 129 | lipoprotein metabolic process (GO:0042157) | 3.49885349 |
| 130 | cytolysis (GO:0019835) | 3.48457986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.29049940 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09994182 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.76812785 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42265652 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24471344 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17453837 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77029846 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99485754 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.92270218 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04609379 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9116351 |
| 12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98544252 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89843641 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68139880 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63208223 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50572935 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48878662 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41707591 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36355209 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33821177 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31131438 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24294468 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17154060 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16766836 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15668444 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11735571 |
| 27 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11051190 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01911190 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00945502 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98200087 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.92817513 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90708187 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89895906 |
| 34 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87348390 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87088490 |
| 36 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85608691 |
| 37 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.84782639 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84278829 |
| 39 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.83548133 |
| 40 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83205710 |
| 41 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80251327 |
| 42 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79709209 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79109208 |
| 44 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76400002 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76370584 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76361885 |
| 47 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.75895020 |
| 48 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75390922 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74875108 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.74581222 |
| 51 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74151960 |
| 52 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.73932219 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73866168 |
| 54 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73460852 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.72495799 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72131198 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71401705 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.71400519 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70580020 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70000323 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69991541 |
| 62 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68703022 |
| 63 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68678365 |
| 64 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.66973813 |
| 65 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.66549407 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.66453983 |
| 67 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65845364 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.65423156 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65355117 |
| 70 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64012633 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 0.63524769 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63137154 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63037235 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.62441797 |
| 75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62126132 |
| 76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61671604 |
| 77 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61418814 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60727552 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60727552 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59713626 |
| 81 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.58988019 |
| 82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58672063 |
| 83 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58373052 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.58224144 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 0.58024100 |
| 86 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.57820156 |
| 87 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.57464437 |
| 88 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.56949630 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.56496880 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55952339 |
| 91 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.55278193 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.55231540 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.55188750 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54980960 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.54622880 |
| 96 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.54399662 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.54174192 |
| 98 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.53892832 |
| 99 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53716059 |
| 100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.53378693 |
| 101 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.53370681 |
| 102 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.53084870 |
| 103 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52788124 |
| 104 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.52633415 |
| 105 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52028210 |
| 106 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.51906716 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51887654 |
| 108 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51695539 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51337562 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.50537792 |
| 111 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50524804 |
| 112 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50276198 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49894682 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49379208 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.49073273 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47371987 |
| 117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46990912 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45644213 |
| 119 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44924680 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44092444 |
| 121 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43178152 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42294064 |
| 123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42057457 |
| 124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42012116 |
| 125 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.41750821 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.40041010 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39284810 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38925876 |
| 129 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.38428239 |
| 130 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37407341 |
| 131 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37339610 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.37092768 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.37006925 |
| 134 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36504147 |
| 135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35882220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.05727596 |
| 2 | MP0005360_urolithiasis | 7.25992564 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.41782971 |
| 4 | MP0005365_abnormal_bile_salt | 6.28313351 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93688763 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14893411 |
| 7 | MP0003252_abnormal_bile_duct | 3.78061869 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58800852 |
| 9 | MP0005083_abnormal_biliary_tract | 3.50884033 |
| 10 | MP0009840_abnormal_foam_cell | 3.27747055 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.99581312 |
| 12 | MP0003195_calcinosis | 2.86877012 |
| 13 | MP0005332_abnormal_amino_acid | 2.73849295 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.37223938 |
| 15 | MP0003868_abnormal_feces_composition | 2.19283810 |
| 16 | MP0000609_abnormal_liver_physiology | 2.13536016 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.12699128 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.07815166 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.04137975 |
| 20 | MP0009697_abnormal_copulation | 1.89321312 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.77687286 |
| 22 | MP0001764_abnormal_homeostasis | 1.71450407 |
| 23 | MP0000566_synostosis | 1.52696681 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48840232 |
| 25 | MP0005451_abnormal_body_composition | 1.37372681 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.29626622 |
| 27 | MP0002132_abnormal_respiratory_system | 1.28311197 |
| 28 | MP0003011_delayed_dark_adaptation | 1.26898655 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.25465221 |
| 30 | MP0003186_abnormal_redox_activity | 1.20702064 |
| 31 | MP0000598_abnormal_liver_morphology | 1.19707601 |
| 32 | MP0003122_maternal_imprinting | 1.17484996 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.15699854 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 1.13975859 |
| 35 | MP0001915_intracranial_hemorrhage | 1.10482113 |
| 36 | MP0005647_abnormal_sex_gland | 1.05050986 |
| 37 | MP0000604_amyloidosis | 1.04138531 |
| 38 | MP0002254_reproductive_system_inflammat | 1.03762413 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.03710069 |
| 40 | MP0002282_abnormal_trachea_morphology | 1.03207309 |
| 41 | MP0002249_abnormal_larynx_morphology | 1.01183132 |
| 42 | MP0009764_decreased_sensitivity_to | 0.98421313 |
| 43 | * MP0009763_increased_sensitivity_to | 0.97973097 |
| 44 | MP0003879_abnormal_hair_cell | 0.97957660 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 0.97513218 |
| 46 | MP0010368_abnormal_lymphatic_system | 0.91751434 |
| 47 | MP0005408_hypopigmentation | 0.90753689 |
| 48 | MP0009642_abnormal_blood_homeostasis | 0.90190499 |
| 49 | MP0008469_abnormal_protein_level | 0.90120649 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.88159065 |
| 51 | MP0002876_abnormal_thyroid_physiology | 0.82447920 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.80933011 |
| 53 | MP0006292_abnormal_olfactory_placode | 0.79917536 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 0.78086678 |
| 55 | MP0005376_homeostasis/metabolism_phenot | 0.77513460 |
| 56 | MP0005670_abnormal_white_adipose | 0.73739773 |
| 57 | MP0003172_abnormal_lysosome_physiology | 0.73200018 |
| 58 | MP0005464_abnormal_platelet_physiology | 0.73109905 |
| 59 | MP0005334_abnormal_fat_pad | 0.72480495 |
| 60 | MP0002971_abnormal_brown_adipose | 0.70435058 |
| 61 | * MP0009765_abnormal_xenobiotic_induced | 0.69402140 |
| 62 | MP0005535_abnormal_body_temperature | 0.68630269 |
| 63 | MP0005448_abnormal_energy_balance | 0.64925986 |
| 64 | MP0004130_abnormal_muscle_cell | 0.63514404 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.63285365 |
| 66 | MP0001756_abnormal_urination | 0.61025861 |
| 67 | MP0001661_extended_life_span | 0.59629660 |
| 68 | MP0005266_abnormal_metabolism | 0.58241477 |
| 69 | MP0005377_hearing/vestibular/ear_phenot | 0.55543519 |
| 70 | MP0003878_abnormal_ear_physiology | 0.55543519 |
| 71 | MP0003329_amyloid_beta_deposits | 0.55057456 |
| 72 | MP0003690_abnormal_glial_cell | 0.54601415 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.54436942 |
| 74 | MP0002928_abnormal_bile_duct | 0.53429086 |
| 75 | MP0009053_abnormal_anal_canal | 0.50850841 |
| 76 | MP0005187_abnormal_penis_morphology | 0.50232990 |
| 77 | MP0003953_abnormal_hormone_level | 0.49231373 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 0.48403007 |
| 79 | MP0003436_decreased_susceptibility_to | 0.48136440 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.44866616 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.44473156 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 0.43870888 |
| 83 | MP0003075_altered_response_to | 0.43793578 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.43238925 |
| 85 | MP0005409_darkened_coat_color | 0.43148974 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.42448437 |
| 87 | MP0005395_other_phenotype | 0.42415405 |
| 88 | MP0008873_increased_physiological_sensi | 0.41709539 |
| 89 | MP0008872_abnormal_physiological_respon | 0.41701368 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.41661315 |
| 91 | MP0003724_increased_susceptibility_to | 0.41500319 |
| 92 | MP0001944_abnormal_pancreas_morphology | 0.41198551 |
| 93 | MP0002822_catalepsy | 0.39724794 |
| 94 | MP0008874_decreased_physiological_sensi | 0.39236042 |
| 95 | MP0005166_decreased_susceptibility_to | 0.38482764 |
| 96 | MP0000249_abnormal_blood_vessel | 0.37831568 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.37608283 |
| 98 | MP0002796_impaired_skin_barrier | 0.35985783 |
| 99 | MP0003959_abnormal_lean_body | 0.35785646 |
| 100 | MP0009785_altered_susceptibility_to | 0.35609678 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.35257160 |
| 102 | MP0005023_abnormal_wound_healing | 0.34776502 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.34602815 |
| 104 | MP0004883_abnormal_blood_vessel | 0.33970653 |
| 105 | MP0003718_maternal_effect | 0.33543528 |
| 106 | MP0005164_abnormal_response_to | 0.33274589 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.32981858 |
| 108 | MP0002970_abnormal_white_adipose | 0.32822903 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.32607188 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.32306082 |
| 111 | MP0009115_abnormal_fat_cell | 0.31735667 |
| 112 | MP0003115_abnormal_respiratory_system | 0.31513322 |
| 113 | MP0006082_CNS_inflammation | 0.31377213 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.31023582 |
| 115 | MP0009672_abnormal_birth_weight | 0.30915607 |
| 116 | MP0001243_abnormal_dermal_layer | 0.30828913 |
| 117 | MP0000579_abnormal_nail_morphology | 0.29180313 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.29138572 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 0.28906384 |
| 120 | MP0002168_other_aberrant_phenotype | 0.28001470 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.27749476 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.27145521 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.26922244 |
| 124 | MP0002092_abnormal_eye_morphology | 0.21925541 |
| 125 | MP0004272_abnormal_basement_membrane | 0.21896881 |
| 126 | MP0003632_abnormal_nervous_system | 0.21002875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.54993426 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.30539189 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.11958193 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.53030381 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.50868607 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.16706573 |
| 7 | Xanthomatosis (HP:0000991) | 6.10389145 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.38786675 |
| 9 | Complement deficiency (HP:0004431) | 5.08983499 |
| 10 | Joint hemorrhage (HP:0005261) | 4.98023363 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.79007476 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.69693160 |
| 13 | Hyperammonemia (HP:0001987) | 4.44079246 |
| 14 | Ketosis (HP:0001946) | 4.35406489 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 4.33493584 |
| 16 | Hyperglycinemia (HP:0002154) | 4.29439073 |
| 17 | Epidermoid cyst (HP:0200040) | 4.27621933 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.25887439 |
| 19 | Fat malabsorption (HP:0002630) | 4.22501454 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.18237121 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.14901806 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13046519 |
| 23 | Hypoglycemic coma (HP:0001325) | 4.12205067 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01379024 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98337691 |
| 26 | Hyperglycinuria (HP:0003108) | 3.81039562 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80480557 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.79500743 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.79500743 |
| 30 | Abnormality of complement system (HP:0005339) | 3.69827430 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59462584 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.45788357 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43025665 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.40363804 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32561339 |
| 36 | Steatorrhea (HP:0002570) | 3.23747507 |
| 37 | Ketoacidosis (HP:0001993) | 3.17659129 |
| 38 | Spontaneous abortion (HP:0005268) | 3.10360303 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98101683 |
| 40 | Purpura (HP:0000979) | 2.96262522 |
| 41 | Myocardial infarction (HP:0001658) | 2.95193091 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.94458412 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.89015035 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.87693429 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.80853987 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.80132554 |
| 47 | Metabolic acidosis (HP:0001942) | 2.75831114 |
| 48 | Skin nodule (HP:0200036) | 2.72265664 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.67421232 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.66018959 |
| 51 | Gout (HP:0001997) | 2.62382326 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56907648 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.56907648 |
| 54 | Menorrhagia (HP:0000132) | 2.54472299 |
| 55 | Acanthocytosis (HP:0001927) | 2.54237260 |
| 56 | Lethargy (HP:0001254) | 2.53067976 |
| 57 | Vascular calcification (HP:0004934) | 2.52530211 |
| 58 | Fair hair (HP:0002286) | 2.50523121 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.46212646 |
| 60 | Gingival bleeding (HP:0000225) | 2.44567232 |
| 61 | Glomerulonephritis (HP:0000099) | 2.43835721 |
| 62 | Irritability (HP:0000737) | 2.38015157 |
| 63 | Pulmonary embolism (HP:0002204) | 2.37502794 |
| 64 | Amyloidosis (HP:0011034) | 2.37123774 |
| 65 | Late onset (HP:0003584) | 2.34467073 |
| 66 | Cholelithiasis (HP:0001081) | 2.34420119 |
| 67 | Mitral stenosis (HP:0001718) | 2.32923658 |
| 68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32001821 |
| 69 | Neonatal hypoglycemia (HP:0001998) | 2.31095619 |
| 70 | Cerebral edema (HP:0002181) | 2.30458817 |
| 71 | Esophageal varix (HP:0002040) | 2.29959994 |
| 72 | Pancreatitis (HP:0001733) | 2.28645521 |
| 73 | Spastic diplegia (HP:0001264) | 2.28019877 |
| 74 | Brushfield spots (HP:0001088) | 2.24905827 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.24067546 |
| 76 | Cholecystitis (HP:0001082) | 2.24067546 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23845003 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.22379386 |
| 79 | Malnutrition (HP:0004395) | 2.20424643 |
| 80 | Neonatal onset (HP:0003623) | 2.19956892 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.19112908 |
| 82 | Thrombophlebitis (HP:0004418) | 2.14562585 |
| 83 | Osteomalacia (HP:0002749) | 2.14539150 |
| 84 | Enlarged kidneys (HP:0000105) | 2.07689775 |
| 85 | Arthropathy (HP:0003040) | 2.07649171 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.05034739 |
| 87 | Bifid scrotum (HP:0000048) | 2.03338836 |
| 88 | Vomiting (HP:0002013) | 2.02757367 |
| 89 | Sensorimotor neuropathy (HP:0007141) | 2.02298030 |
| 90 | Poikilocytosis (HP:0004447) | 2.02183155 |
| 91 | Opisthotonus (HP:0002179) | 1.99108180 |
| 92 | Hyperglycemia (HP:0003074) | 1.98669723 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 1.97086983 |
| 94 | Symptomatic seizures (HP:0011145) | 1.92195353 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 1.89485672 |
| 96 | Rickets (HP:0002748) | 1.88654896 |
| 97 | Renal cortical cysts (HP:0000803) | 1.88316533 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 1.88121152 |
| 99 | Gangrene (HP:0100758) | 1.86919570 |
| 100 | Elevated hepatic transaminases (HP:0002910) | 1.84402932 |
| 101 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83883609 |
| 102 | Alkalosis (HP:0001948) | 1.83042555 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 1.82733650 |
| 104 | Hydroxyprolinuria (HP:0003080) | 1.82733650 |
| 105 | Reticulocytosis (HP:0001923) | 1.82352942 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 1.82074715 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 1.81755131 |
| 108 | Epistaxis (HP:0000421) | 1.78980767 |
| 109 | Acute hepatic failure (HP:0006554) | 1.78726387 |
| 110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77418840 |
| 111 | Nephritis (HP:0000123) | 1.74112854 |
| 112 | Blue irides (HP:0000635) | 1.68955854 |
| 113 | Increased serum ferritin (HP:0003281) | 1.66506963 |
| 114 | Generalized hypopigmentation of hair (HP:0011358) | 1.64969391 |
| 115 | Increased mean platelet volume (HP:0011877) | 1.63350664 |
| 116 | Joint swelling (HP:0001386) | 1.61043223 |
| 117 | Elevated alkaline phosphatase (HP:0003155) | 1.58306989 |
| 118 | Increased serum pyruvate (HP:0003542) | 1.52171515 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.51378257 |
| 120 | Megaloblastic anemia (HP:0001889) | 1.50491749 |
| 121 | Facial shape deformation (HP:0011334) | 1.49566367 |
| 122 | Potter facies (HP:0002009) | 1.49566367 |
| 123 | Impaired platelet aggregation (HP:0003540) | 1.47371951 |
| 124 | Abnormal platelet function (HP:0011869) | 1.47371951 |
| 125 | Hyperphosphaturia (HP:0003109) | 1.46681812 |
| 126 | Hypochromic anemia (HP:0001931) | 1.44623316 |
| 127 | Abnormal platelet volume (HP:0011876) | 1.44478756 |
| 128 | Abnormal delivery (HP:0001787) | 1.35186477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.18150531 |
| 2 | ERN1 | 4.63573717 |
| 3 | FGFR4 | 4.24219738 |
| 4 | SIK1 | 4.03514453 |
| 5 | INSRR | 3.44852521 |
| 6 | TAOK3 | 3.36133935 |
| 7 | PIK3CG | 3.01476161 |
| 8 | ERBB4 | 2.41275670 |
| 9 | FLT3 | 2.40336355 |
| 10 | NTRK3 | 2.39410788 |
| 11 | PKN2 | 2.28229814 |
| 12 | WNK4 | 2.23567395 |
| 13 | MST1R | 2.00998215 |
| 14 | TRIB3 | 1.92376062 |
| 15 | MAPK11 | 1.89199190 |
| 16 | MAP2K4 | 1.87954761 |
| 17 | FRK | 1.76407108 |
| 18 | PTK6 | 1.72965635 |
| 19 | MAPK15 | 1.57290266 |
| 20 | TYK2 | 1.55453300 |
| 21 | TYRO3 | 1.53263585 |
| 22 | SIK2 | 1.51428499 |
| 23 | PDGFRA | 1.51018064 |
| 24 | NEK9 | 1.48882047 |
| 25 | EPHA4 | 1.43809264 |
| 26 | CDK12 | 1.39206252 |
| 27 | MAP3K7 | 1.29121037 |
| 28 | DAPK2 | 1.23002522 |
| 29 | LATS1 | 1.20974739 |
| 30 | JAK2 | 1.20093856 |
| 31 | KDR | 1.19974306 |
| 32 | FGFR1 | 1.15934524 |
| 33 | ABL2 | 1.10890158 |
| 34 | DDR2 | 1.05704681 |
| 35 | MAP3K14 | 1.04549874 |
| 36 | EPHA3 | 1.03944909 |
| 37 | TBK1 | 1.02886720 |
| 38 | MAP2K3 | 0.99886388 |
| 39 | SGK223 | 0.99814168 |
| 40 | SGK494 | 0.99814168 |
| 41 | TGFBR2 | 0.99231906 |
| 42 | MAP3K10 | 0.97483358 |
| 43 | PRKAA2 | 0.95468745 |
| 44 | EPHB1 | 0.95161526 |
| 45 | PIK3CA | 0.95142649 |
| 46 | PRKG2 | 0.95050812 |
| 47 | GRK6 | 0.89688726 |
| 48 | JAK1 | 0.88084323 |
| 49 | AKT3 | 0.85076150 |
| 50 | MAP2K2 | 0.84866370 |
| 51 | MAPK4 | 0.83320592 |
| 52 | MAP2K6 | 0.83177667 |
| 53 | TIE1 | 0.83135161 |
| 54 | MET | 0.82699929 |
| 55 | CDK6 | 0.81429382 |
| 56 | FGFR2 | 0.81216067 |
| 57 | PINK1 | 0.80422348 |
| 58 | ERBB2 | 0.79555900 |
| 59 | DYRK1B | 0.73884809 |
| 60 | IRAK3 | 0.72943485 |
| 61 | MAP3K3 | 0.72577293 |
| 62 | PRKCZ | 0.70955135 |
| 63 | SGK1 | 0.70841288 |
| 64 | PRKACG | 0.69133845 |
| 65 | CSK | 0.68885930 |
| 66 | SGK3 | 0.68366943 |
| 67 | PTK2 | 0.67296765 |
| 68 | MARK2 | 0.67046994 |
| 69 | MAP3K11 | 0.66134000 |
| 70 | WNK1 | 0.66102307 |
| 71 | FGFR3 | 0.65829394 |
| 72 | EPHA2 | 0.64732286 |
| 73 | MAPK12 | 0.64203245 |
| 74 | PRKG1 | 0.62770920 |
| 75 | IKBKE | 0.61497077 |
| 76 | SMG1 | 0.61288471 |
| 77 | KIT | 0.61257867 |
| 78 | PDPK1 | 0.57771808 |
| 79 | FGR | 0.57007504 |
| 80 | CSNK1E | 0.56498173 |
| 81 | GSK3A | 0.55356881 |
| 82 | IGF1R | 0.55326909 |
| 83 | PRKAA1 | 0.54934363 |
| 84 | PRKACA | 0.53849166 |
| 85 | BCR | 0.53456902 |
| 86 | CAMK2G | 0.53421909 |
| 87 | NTRK2 | 0.53234319 |
| 88 | CSNK1D | 0.52909908 |
| 89 | RET | 0.52566949 |
| 90 | EEF2K | 0.50525193 |
| 91 | MAP2K1 | 0.50259664 |
| 92 | SRC | 0.50105864 |
| 93 | CDK4 | 0.49776133 |
| 94 | FER | 0.49763165 |
| 95 | CAMKK1 | 0.48931327 |
| 96 | DYRK1A | 0.48909295 |
| 97 | ZAP70 | 0.48880520 |
| 98 | CAMK4 | 0.48795690 |
| 99 | STK38L | 0.48465823 |
| 100 | CDC42BPA | 0.48141188 |
| 101 | MAP3K13 | 0.48074481 |
| 102 | TNK2 | 0.47084693 |
| 103 | MAPK7 | 0.46639243 |
| 104 | RPS6KA3 | 0.45796553 |
| 105 | MAP3K1 | 0.44718246 |
| 106 | PRPF4B | 0.44629406 |
| 107 | RIPK1 | 0.43854197 |
| 108 | PDGFRB | 0.40501224 |
| 109 | MTOR | 0.40405371 |
| 110 | PDK1 | 0.40027349 |
| 111 | MAP4K1 | 0.38115148 |
| 112 | CAMK1D | 0.37104784 |
| 113 | PRKCQ | 0.36658635 |
| 114 | CSF1R | 0.36500038 |
| 115 | RPS6KB1 | 0.34806875 |
| 116 | GRK1 | 0.33781450 |
| 117 | MAPKAPK3 | 0.31165489 |
| 118 | MAPK10 | 0.30606665 |
| 119 | CDK7 | 0.29533860 |
| 120 | PDK2 | 0.28119816 |
| 121 | MAPK8 | 0.27551719 |
| 122 | PRKCB | 0.27236016 |
| 123 | MAPK1 | 0.27149051 |
| 124 | CSNK2A1 | 0.27094734 |
| 125 | IRAK1 | 0.26393845 |
| 126 | ICK | 0.25035112 |
| 127 | EGFR | 0.24291732 |
| 128 | PRKCA | 0.24193573 |
| 129 | PRKACB | 0.24171740 |
| 130 | MAPK3 | 0.24167354 |
| 131 | MAP3K2 | 0.23608363 |
| 132 | CSNK1G1 | 0.22668603 |
| 133 | MATK | 0.21564176 |
| 134 | TAOK2 | 0.21507515 |
| 135 | SGK2 | 0.21371775 |
| 136 | BTK | 0.21213209 |
| 137 | STK38 | 0.21182899 |
| 138 | MAP3K5 | 0.19734061 |
| 139 | CHUK | 0.19324585 |
| 140 | IKBKB | 0.19206323 |
| 141 | JAK3 | 0.18493437 |
| 142 | MAP3K6 | 0.17002805 |
| 143 | PRKCG | 0.16553093 |
| 144 | STK3 | 0.16051260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43377232 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.51550536 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34749772 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26007448 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05155183 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80392859 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68412360 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62472609 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60690362 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58973488 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47158697 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40951224 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25477880 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11572331 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10762910 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04815762 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95721679 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92955811 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91188924 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89184457 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85486577 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83062366 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76037050 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75603267 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72036846 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68223100 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67520425 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66257639 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62206180 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61316883 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60447046 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58203878 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56726143 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54290039 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53447660 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47617336 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46204458 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45510133 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43782810 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39646947 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39474715 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33159555 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30469327 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29066197 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25877400 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23839361 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.20445083 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16563839 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06298417 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03164221 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00886865 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00538894 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96012299 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94073129 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92039526 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85474040 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83541296 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80512237 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78581502 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77590757 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74291437 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66800653 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66432410 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54606610 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50583848 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46540333 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45530775 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.45412073 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42756788 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36346548 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34867061 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31216369 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.30634848 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30223814 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.26896796 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21844252 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18263668 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.13739989 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11873262 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10811462 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02431675 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01509957 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.00210361 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2194125 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.2192163 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2095646 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2059375 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1974018 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1859214 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.1812467 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1699894 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1547123 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1454612 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1450706 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1424126 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1371852 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1318913 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1111346 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1093140 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1072215 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1024334 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0994347 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0915935 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0842289 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0766454 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0691225 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0660324 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0394854 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0315761 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0122928 |

